Streetbeat News

Stock Prices

CME

Goldman Sachs analyst Alexander Blostein downgraded CME Group (CME) from Neutral to Sell and set a price target of $195.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:56 am

SCHW

Goldman Sachs analyst Alexander Blostein downgraded Charles Schwab (NYSE:SCHW) from Buy to Neutral and set a price target of $71.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:53 am

SOFI

Keefe, Bruyette & Woods analyst Michael Perito downgraded SoFi Technologies (SOFI) from Market Perform to Underperform and reduced the price target from $7.5 to $6.5.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:49 am

RKT

Keefe, Bruyette & Woods analyst Bose George downgraded Rocket Companies (NYSE:RKT) from Market Perform to Underperform and set a price target of $10.75.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:47 am

TEVA

Piper Sandler analyst David Amsellem has upgraded Teva Pharmaceutical Industries (NYSE:TEVA) from Underweight to Neutral and increased the price target from $8 to $12.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:44 am

STT

Goldman Sachs analyst Alexander Blostein upgraded State Street (NYSE:STT) from Neutral to Buy and set a price target of $92.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:43 am

AMP

Goldman Sachs analyst Alexander Blostein has upgraded Ameriprise Financial (NYSE:AMP) from Neutral to Buy and set a price target of $452.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:41 am

ARQT

Mizuho analyst Uy Ear has upgraded Arcutis Biotherapeutics (NASDAQ:ARQT) from Neutral to Buy and increased the price target from $4 to $8, indicating a more positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:39 am

GLD

SPY

The U.S. national debt has surpassed $34 trillion, with concerns about its impact on economic growth, government spending, and financial markets. Economists warn of potential crises, and Morgan Stanley's Lisa Shalett recommends shifting to real assets like gold. The SPDR Gold Shares (GLD) rose about 13% in 2023, while the SPDR S&P 500 ETF Trust (SPY) fell 0.56% in a recent session.

Portfolio Pulse from Shanthi Rexaline

January 03, 2024 | 8:48 am

BLK

BTCUSD

BTDR

AllianceBernstein analysts predict Bitcoin (BTC) will reach $80,000 by end of 2024, driven by a spot ETF approval, the halving event, and rising corporate demand. Bitcoin surged 150% in 2023 and started 2024 strong. The SEC is expected to approve a spot Bitcoin ETF by ARK Investments and 21Shares, with BlackRock Inc also likely to receive approval. Spot ETFs could lead to a temporary selloff but are expected to attract institutional inflows, with $15 billion projected in 2024 and 10% of Bitcoin under ETFs by 2028.

Portfolio Pulse from Benzinga Neuro

January 03, 2024 | 8:46 am